| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |